Pharmacology of rasagiline (N-propargyl-1R-aminoindan).
Finberg
J P
JP
Rapapport Faculty of Medicine, Technion, Haifa, Israel.
Lamensdorf
I
I
Weinstock
M
M
Schwartz
M
M
Youdim
M B
MB
D000818:Animals; D016923:Cell Death / Q000187:drug effects; D002478:Cells, Cultured; D006259:Craniocerebral Trauma / Q000503:physiopathology; D004298:Dopamine / Q000378:metabolism; D018698:Glutamic Acid / Q000494:pharmacology; D006624:Hippocampus / Q000166:cytology / Q000187:drug effects; D007189:Indans / Q000494:pharmacology*; D008297:Male; D018782:Maze Learning / Q000187:drug effects; D008995:Monoamine Oxidase / Q000187:drug effects; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D018696:Neuroprotective Agents / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D011930:Reaction Time / Q000187:drug effects
D007189:Indans; D008996:Monoamine Oxidase Inhibitors; D018696:Neuroprotective Agents; C031967:rasagiline; D018698:Glutamic Acid; D008995:Monoamine Oxidase; D004298:Dopamine